-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Su Xuejun, Chairman of Shijiazhuang Sihua Pharmaceutical Group, Awarded the Title of “Meritorious Entrepreneur”
Category:
发布时间：2022-11-02
【概要描述】
On November 1, the 15th CIP Conference—China Health Industry (International) Ecosystem Conference, themed “Building a Patient-Centric Value Circle: Dual-Drive Development Fuels New Growth in the Health Industry,” grandly opened in Boao, Hainan. Su Xuejun, Chairman of Shijiazhuang Sihua Pharmaceutical Group, was honored with the title of “Distinguished Entrepreneur.”
On November 1, the 15th CPHI China—China Health Industry (International) Ecosystem Conference, themed “Building a Patient-Centric Value Circle: Dual-Drive Development Fuels New Growth in the Health Industry,” grandly opened in Boao, Hainan.
In tribute to China’s health-industry entrepreneurial community and in recognition of the enduring brilliance of the entrepreneurial spirit, the conference organizing committee has established the “Meritorious Entrepreneur” award. Su Xuejun, Chairman of Shijiazhuang Sihua Pharmaceutical Group, has been honored with this prestigious title. In recent years, Shijiazhuang Sihua Pharmaceutical Group has grounded itself in the new stage of development, embraced the new development philosophy, and forged a new development pattern. By benchmarking against industry leaders, taking proactive measures, and focusing on cutting-edge technologies and market demands, the company has vigorously built a strategic stronghold centered on innovation-driven growth. As a result, it has cultivated a new business model characterized by the gradual refinement and integration of its industrial chain, embarked on an innovative path of high-quality development, and emerged as a key force in the innovation and advancement of the pharmaceutical industry. The company has now ranked among the Top 100 Chinese pharmaceutical enterprises and been recognized as a National Demonstration Enterprise for Technological Innovation.
According to reports, the renowned Xipu Conference has been successfully held for 15 sessions since 2008. To date, it has integrated a wide range of functions, including forward-looking thought leadership and information exchange, strategic collaboration and communication, high-end industry branding, and cross-sectoral integration, thereby championing mainstream values in China’s health industry under the Xipu spirit of “responsibility and commitment” and leading industrial transformation, innovation, and ecosystem integration.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091